美年健康
(002044)
| 流通市值：185.07亿 | | | 总市值：187.10亿 |
| 流通股本：38.72亿 | | | 总股本：39.14亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 10,893,535,007.49 | 7,217,331,650.49 | 4,405,411,317.91 | 2,095,573,428.4 |
| 营业收入 | 10,893,535,007.49 | 7,217,331,650.49 | 4,405,411,317.91 | 2,095,573,428.4 |
| 二、营业总成本 | 9,995,374,869.11 | 6,831,154,198.18 | 4,364,142,856.17 | 2,232,685,341.69 |
| 营业成本 | 6,232,314,171.75 | 4,342,226,166.45 | 2,768,833,315.3 | 1,413,922,699.02 |
| 税金及附加 | 6,484,387.86 | 2,831,869.02 | 2,097,463.28 | 2,101,274.97 |
| 销售费用 | 2,562,904,527.26 | 1,651,969,466.69 | 1,054,536,011.08 | 548,750,375.19 |
| 管理费用 | 831,999,131.98 | 577,153,870.14 | 374,022,617.99 | 186,991,133.9 |
| 研发费用 | 62,649,103.69 | 41,614,528.18 | 26,511,668.41 | 12,756,472.64 |
| 财务费用 | 299,023,546.57 | 215,358,297.7 | 138,141,780.11 | 68,163,385.97 |
| 其中:利息费用 | 303,676,769.47 | 219,224,654.15 | 141,491,808.42 | 69,353,746.08 |
| 其中:利息收入 | 14,053,986.4 | 10,458,219.6 | 8,011,924.93 | 4,164,703.28 |
| 加:公允价值变动收益 | 41,902,536.02 | -6,378,990.62 | -1,933,339.97 | -796.72 |
| 加:投资收益 | 7,577,768.84 | -8,275,796.77 | -6,157,021.43 | -8,822,289.8 |
| 资产处置收益 | -6,894,558.26 | -3,162,592.54 | -2,490,655.61 | -1,970,846.85 |
| 资产减值损失(新) | -88,787,158.43 | -1,441,894.19 | -685,618.84 | -685,618.84 |
| 信用减值损失(新) | 8,518,225.96 | -18,198,902.85 | 14,442,812.64 | -17,005,481 |
| 其他收益 | 23,228,446.87 | 9,829,023.42 | 7,485,819.37 | 4,764,718.07 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 883,705,399.38 | 358,548,298.76 | 51,930,457.9 | -160,832,228.43 |
| 加:营业外收入 | 5,690,171.93 | 7,585,903.4 | 5,071,661.5 | 1,335,577.42 |
| 减:营业外支出 | 41,340,248.09 | 14,163,161.69 | 8,328,139.62 | 3,522,462.62 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 848,055,323.22 | 351,971,040.47 | 48,673,979.78 | -163,019,113.63 |
| 减:所得税费用 | 179,231,846.79 | 41,939,227.02 | -6,396,422.27 | -922,567.63 |
| 六、净利润 | 668,823,476.43 | 310,031,813.45 | 55,070,402.05 | -162,096,546 |
| 持续经营净利润 | 668,823,476.43 | 310,031,813.45 | 55,070,402.05 | -162,096,546 |
| 归属于母公司股东的净利润 | 505,621,135.98 | 225,595,778.13 | 10,144,667.02 | -167,198,010.95 |
| 少数股东损益 | 163,202,340.45 | 84,436,035.32 | 44,925,735.03 | 5,101,464.95 |
| (一)基本每股收益 | 0.13 | 0.06 | 0 | -0.04 |
| (二)稀释每股收益 | 0.13 | 0.06 | 0 | -0.04 |
| 八、其他综合收益 | 231,195.48 | 350,710.14 | 485,520.41 | -182,802.34 |
| 归属于母公司股东的其他综合收益 | 121,362.31 | 147,002.82 | 243,320.31 | -53,670.28 |
| 九、综合收益总额 | 669,054,671.91 | 310,382,523.59 | 55,555,922.46 | -162,279,348.34 |
| 归属于母公司股东的综合收益总额 | 505,742,498.29 | 225,742,780.95 | 10,387,987.33 | -167,251,681.23 |
| 归属于少数股东的综合收益总额 | 163,312,173.62 | 84,639,742.64 | 45,167,935.13 | 4,972,332.89 |
| 公告日期 | 2024-04-25 | 2023-10-31 | 2023-08-30 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | | | |